Gestational Diabetes Mellitus
- Glucose intolerance with onset or first recognition during pregnancy characterized by β-cell function that is unable to meet the body’s insulin needs.
- During pregnancy, gestational diabetes requires treatment to normalize maternal blood glucose levels to avoid complications in the infant. After pregnancy, 5% to 10% of women with gestational diabetes are found to have type 2 diabetes. Women who have had gestational diabetes have a 20% to 50% chance of developing diabetes in the next 5-10 years.
- Insulin resistance begins in mid pregnancy and progresses through the third trimester, a result of maternal adiposity and effects of placental hormones. β -cells usually make more insulin to compensate for resistance – when they cannot meet the needs hyperglycemia occurs.
- Prevalence higher
- in less physically active women.
- In older women
- In women with higher BMI
- In those with a strong family history of diabetes
Pathophysiology of Gestational Diabetes Mellitus
- Insulin resistance increases as pregnancy progress.
- Increased insulin resistance due to increased maternal adiposity and effects of placental hormones.
- Hormones produced by the placenta: Human chorionic somatomammotropin (HCS), cortisol, estrogen, progesterone.
- As pregnancy progresses and placenta grows, production of hormones increases, thus leading to increased insulin resistance.
- GDM occurs when insulin secretion is not sufficient to offset the decrease in insulin sensitivity.
Risk Factors
High Risk
- Obesity
- Diabetes in 1st degree relative
- Previous
- history of GDM or glucose intolerance
- complicated pregnancy
- infant with macrosomia > 3.5 kg
- Older Age
- High risk ethnic group; South Asian, East Asian, Indigenous American or Australian, Hispanic
- Polycystic Ovary Syndrome
Low Risk
- Age less than 25 years
- No previous poor pregnancy outcomes
- No diabetes in 1st degree relatives
- Normal prepregnancy weight and weight gain during pregnancy
- No history of abnormal glucose tolerance
- Short term risks for the mother
- Development of gestational hypertension, worsening essential hypertension or development of preeclampsia
- Operative delivery - related to macrosomia
- Polyhydramnios
- Premature labour
- Long term risks for mother
- Development of type 2 diabetes in next ~10 years (30-60% depending on population)
- Development of cardiovascular disease
- Short term risks for the baby
- Macrosomia
- Neonatal hypoglycemia
- Jaundice
- Preterm birth
- Birth injury
- Hypocalcemia/ hypomagnesimia
- Respiratory distress syndrome
- Long term risks for the baby
- Obesity
- Type 2 diabetes
Non-modifiable
- Age > 40
- Family history and genetic disposition
- Ethnicity
- History of impaired glucose tolerance and impaired fasting glucose.
- Vascular disease
- History of gestational diabetes or delivery of macrosomic baby.
- polycystic ovary diseases
- Schezoprenia
- hypertension
- Dyslipidaemia
Modifiable
- Abdominal or central obesity
- Over weight
- Physical inactivity
- Dietary factors
Signs and Symptoms
Women with gestational diabetes usually have no symptoms or mild, non-life-threatening symptoms, according to the NIH. These symptoms are mostly related to abnormal blood sugar levels, and can include fatigue, excessive thirst and increased urination.
| Polyuria
|
| Polydipsia
|
| Polyphagia
|
| Weight loss
|
| Visual disturbance |
| Fatigue
|
| Infections |
| Hunger |
| Sexual Problems |
|---|